Isocarboxazid is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of depressive disorders, including those associated with anxiety, panic attacks, and phobias. It functions by inhibiting… Read more
Isocarboxazid is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of depressive disorders, including those associated with anxiety, panic attacks, and phobias. It functions by inhibiting the monoamine oxidase enzyme, which leads to increased concentrations of neurotransmitters in the brain. The category contains essential reference standards, including the active pharmaceutical ingredient, related impurities, and stable isotope-labelled compounds. These materials are critical for comprehensive impurity profiling and the validation of analytical methods during drug development and quality control. By utilizing well-characterized standards, laboratories can ensure the accuracy of chromatographic assays and the precise identification of degradation products or synthetic byproducts. These analytical tools support regulatory compliance and strict quality assessments required throughout the pharmaceutical lifecycle, ensuring that stability and purity are maintained to rigorous scientific specifications.